SF
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
Traitements médicamenteux séquentiels de l’ostéoporose | Revue médicale suisse | 2025 | 3 | 0 | |||
Rheumatoid arthritis and subsequent fracture risk : an individual person meta-analysis to update FRAX | Osteoporosis international | 2025 | 15 | 0 | |||
Romosozumab Improves Tissue Thickness-Adjusted Trabecular Bone Score in Women With Osteoporosis and Diabetes | Journal of clinical endocrinology & metabolism | 2025 | 14 | 3 | |||
Ostéoporose : ces malades qu’on ignore malgré des traitements efficaces | Revue médicale suisse | 2025 | 4 | 0 | |||
Efficacité clinique des traitements de l’ostéoporose | Revue médicale suisse | 2025 | 3 | 0 | |||
Prise en charge de la fragilité osseuse du patient diabétique | Revue médicale suisse | 2025 | 7 | 0 | |||
Alternated activation with relaxation of periosteum stimulates bone modeling and remodeling | Scientific reports | 2024 | 19 | 7 | |||
Sclerostin blockade inhibits bone resorption through PDGF receptor signaling in osteoblast lineage cells | JCI insight | 2024 | 82 | 66 | |||
The challenge of hypophosphatasia diagnosis in adults : results from the HPP International Working Group Literature Surveillance | Osteoporosis international | 2024 | 13 | 1 | |||
Effects of Dalcroze eurhythmics exercise versus multicomponent exercise on physical and cognitive function, and falls in older adults : the EPHYCOS randomized controlled trial | Advanced biology | 2024 | 36 | 29 | |||
Romosozumab followed by denosumab versus denosumab only : a post hoc analysis of FRAME and FRAME extension | Journal of bone and mineral research | 2024 | 27 | 32 | |||
Reduced sclerostin expression in human atherosclerotic plaques links to ischemic stroke | Journal of the American Heart Association. Cardiovascular and cerebrovascular disease | 2024 | 21 | 10 | |||
Fracture risk based on high-resolution peripheral quantitative computed tomography measures does not vary with age in older adults-the bone microarchitecture international consortium prospective cohort study | Journal of bone and mineral research | 2024 | 29 | 0 | |||
Validation of a fall rate prediction model for community-dwelling older adults : a combined analysis of three cohorts with 1850 participants | BMC geriatrics | 2024 | 10 | 6 | |||
Maladies osseuses : ce qui a changé en 2023 | Revue médicale suisse | 2024 | 86 | 3 | |||
Short-term risk of fracture is increased by deficits in cortical and trabecular bone microarchitecture independent of DXA BMD and FRAX : bone microarchitecture international consortium (BoMIC) prospective cohorts | Journal of bone and mineral research | 2024 | 135 | 135 | |||
Hypophosphatasia diagnosis : current state of the art and proposed diagnostic criteria for children and adults | Osteoporosis international | 2024 | 14 | 6 | |||
3D-modeling from hip DXA shows improved bone structure with romosozumab followed by denosumab or alendronate | Journal of bone and mineral research | 2024 | 76 | 35 | |||
Proposed diagnostic criteria for the diagnosis of hypophosphatasia in children and adolescents : results from the HPP International Working Group | Osteoporosis international | 2024 | 16 | 10 | |||
A meta-analysis of previous falls and subsequent fracture risk in cohort studies | Osteoporosis international | 2024 | 44 | 0 | |||
Effect of Antidiabetic Drugs on Bone Health in Patients with Normal Renal Function and in Chronic Kidney Disease (CKD) : Insight into Clinical Challenges in the Treatment of Type 2 Diabetes | Journal of clinical medicine | 2023 | 44 | 24 | |||
NADPH oxidase 4 deficiency attenuates experimental osteoarthritis in mice | RMD open | 2023 | 174 | 57 | |||
Nouveaux critères de remboursement du dosage de la vitamine D : et nos patients migrants ? | Revue médicale suisse | 2023 | 59 | 49 | |||
High frequency of heterozygous rare variants of the SLC34A1 and SLC9A3R1 genes in patients with atypical femur fracture | European journal of endocrinology | 2023 | 197 | 38 | |||
2D-3D reconstruction of the proximal femur from DXA scans: Evaluation of the 3D-Shaper software | Frontiers in bioengineering and biotechnology | 2023 | 75 | 45 | |||
Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women : systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials | BMJ | 2023 | 53 | 11 | |||
Unusual phosphaturic mesenchymal tumor mimicking osteoid osteoma | Radiology case reports | 2023 | 114 | 62 | |||
Biochemical Markers of Bone Fragility in Patients With Diabetes | The Journal of clinical endocrinology and metabolism | 2023 | 66 | 0 | |||
A Fracture Risk Assessment Tool for High Resolution Peripheral Quantitative Computed Tomography | Journal of bone and mineral research | 2023 | 99 | 75 | |||
The effects of time‐restricted eating and weight loss on bone metabolism and health: a 6‐month randomized controlled trial | Obesity | 2023 | 192 | 21 | |||
Mechanisms underlying the long-term and withdrawal effects of denosumab therapy on bone | Nature reviews. Rheumatology | 2023 | 33 | 0 | |||
Functional brain changes in sarcopenia: evidence for differential central neural mechanisms in dynapenic older women | Aging Clinical and Experimental Research | 2023 | 118 | 39 | |||
Previous fracture and subsequent fracture risk : a meta-analysis to update FRAX | Osteoporosis international | 2023 | 49 | 29 | |||
Development of a personalized fall rate prediction model in community-dwelling older adults: a negative binomial regression modelling approach | BMC geriatrics | 2023 | 52 | 43 | |||
Time for Revival of Bone Biopsy with Histomorphometric Analysis in Chronic Kidney Disease (CKD): Moving from Skepticism to Pragmatism | Nutrients | 2022 | 126 | 105 | |||
Romosozumab efficacy and safety in European patients enrolled in the FRAME trial | Osteoporosis international | 2022 | 169 | 68 | |||
Associations of Calcium Intake and Calcium from Various Sources with Blood Lipids in a Population of Older Women and Men with High Calcium Intake | Nutrients | 2022 | 131 | 77 | |||
Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis plan | Osteoporosis international | 2022 | 207 | 0 | |||
Fracture risk following an atypical femoral fracture | Journal of bone and mineral research | 2022 | 210 | 226 | |||
Regeneration of Craniofacial Bone Induced by Periosteal Pumping | Tissue engineering. Part C, Methods. | 2022 | 178 | 2 | |||
Bone Microarchitecture Phenotypes Identified in Older Adults Are Associated With Different Levels of Osteoporotic Fracture Risk | Journal of bone and mineral research | 2022 | 313 | 350 | |||
Pumping the Periosteum : A Feasibility Study | Annals of plastic surgery | 2022 | 8 | 0 | |||
Prevalence of low serum alkaline phosphatase and hypophosphatasia in adult patients with atypical femur fractures | Calcified tissue international | 2022 | 331 | 276 | |||
Pathophysiology of vascular calcification and bone loss: linked disorders of ageing? | Nutrients | 2021 | 200 | 115 | |||
Primary mouse osteoblast and osteoclast culturing and analysis | STAR protocols | 2021 | 352 | 176 | |||
Overweight-obesity is associated with decreased vitamin K2 levels in hemodialysis patients | Clinical chemistry and laboratory medicine | 2021 | 254 | 135 | |||
A Novel HR-pQCT Image Registration Approach Reveals Sex-Specific Changes in Cortical Bone Retraction With Aging | Journal of Bone and Mineral Research | 2021 | 168 | 0 | |||
Reference microarchitectural values measured by HR-pQCT in a Franco-Swiss cohort of young adult women | Osteoporosis international | 2021 | 125 | 0 | |||
Covid 19 - vitamine D - traitement de l'ostéoporose | Revue médicale suisse | 2021 | 184 | 169 | |||
Bone fragility in patients affected by congenital diseases non skeletal in origin | Orphanet Journal of Rare Diseases | 2021 | 176 | 103 | |||
Développement et évaluation des filières de l'ostéoporose en Suisse | Revue médicale suisse | 2021 | 273 | 267 | |||
European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4–G5D | Nephrology Dialysis Transplantation | 2021 | 211 | 4 | |||
Denosumab in the Treatment of Osteoporosis: 10 Years Later: A Narrative Review | Advances in therapy | 2021 | 141 | 190 | |||
Vertebral fracture: epidemiology, impact and use of DXA vertebral fracture assessment in fracture liaison services | Osteoporosis international | 2021 | 208 | 118 | |||
Ostéoporose - Nouvelle molécule, nouvelles directives | Revue médicale suisse | 2021 | 93 | 45 | |||
RANKL‐Induced Increase in Cathepsin K Levels Restricts Cortical Expansion in a Periostin‐Dependent Fashion: A Potential New Mechanism of Bone Fragility | Journal of Bone and Mineral Research | 2021 | 242 | 1 | |||
Lack of Adiponectin Drives Hyperosteoclastogenesis in Lipoatrophic Mice | Frontiers in Cell and Developmental Biology | 2021 | 178 | 74 | |||
Romosozumab Followed by Antiresorptive Treatment Increases the Probability of Achieving Bone Mineral Density Treatment Goals | JBMR plus | 2021 | 155 | 80 | |||
Metformin: is it the well wisher of bone beyond glycemic control in diabetes mellitus? | Calcified tissue international | 2021 | 225 | 0 | |||
Oral calcitriol use, vertebral fractures, and vitamin K in hemodialysis patients: a cross‐sectional study | Journal of bone and mineral research | 2021 | 148 | 0 | |||
The vessels-bone axis: iliac artery calcifications, vertebral fractures and vitamin K from VIKI study | Nutrients | 2021 | 146 | 120 | |||
Short or long-term osteoporosis therapy with denosumab ? | Journal of clinical endocrinology & metabolism | 2021 | 121 | 79 | |||
Mechanically Driven Counter‐Regulation of Cortical Bone Formation in Response to Sclerostin‐Neutralizing Antibodies | Journal of Bone and Mineral Research | 2021 | 202 | 0 | |||
Reliability and validity of an adapted hip abductor strength measure as a potential new fall risk assessment for older persons: a study protocol | BMC Geriatrics | 2021 | 227 | 97 | |||
Higher serum levels of a cathepsin K–generated periostin fragment are associated with fractures in postmenopausal women with primary hyperparathyroidism: a pilot study | Osteoporosis international | 2021 | 89 | 0 | |||
Romosozumab : un nouveau traitement de l'ostéoporose sévère | Revue médicale suisse | 2021 | 1,095 | 367 | |||
Associations between age-related changes in bone microstructure and strength and dietary acid load in a cohort of community-dwelling, healthy men and postmenopausal women | The American Journal of Clinical Nutrition | 2020 | 254 | 5 | |||
A patient-level key performance indicator set to measure the effectiveness of fracture liaison services and guide quality improvement | Osteoporosis International | 2020 | 267 | 138 | |||
2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO) | Swiss Medical Weekly | 2020 | 416 | 233 | |||
Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOF | The Journal of clinical endocrinology and metabolism | 2020 | 123 | 120 | |||
Perspectives on the non-invasive evaluation of femoral strength in the assessment of hip fracture risk | Osteoporosis International | 2020 | 200 | 0 | |||
Sevelamer use, vitamin K levels, vascular calcifications and vertebral fractures in hemodialysis patients: results from the VIKI study | Journal of Bone and Mineral Research | 2020 | 185 | 398 | |||
Ostéoporose | Revue médicale suisse | 2020 | 95 | 174 | |||
Hand grip strength and early mortality after hip fracture | Archives of Osteoporosis | 2020 | 166 | 0 | |||
Denosumab in postmenopausal women with osteoporosis and diabetes: Subgroup analysis of FREEDOM and FREEDOM extension | Bone | 2020 | 314 | 2 | |||
Favorable skeletal benefit/risk of long-term denosumab therapy: A virtual-twin analysis of fractures prevented relative to skeletal safety events observed | Bone | 2020 | 264 | 2 | |||
Zoledronate Following Denosumab Discontinuation: Partial Reassurance but No Confidence | Journal of Bone and Mineral Research | 2020 | 249 | 5 | |||
The role of hip abductor strength in identifying older persons at risk of falls: a diagnostic accuracy study | Clinical Interventions in Aging | 2020 | 330 | 111 | |||
T-score as an indicator of fracture risk during treatment with romosozumab or alendronate in the ARCH trial | Journal of Bone and Mineral Research | 2020 | 256 | 72 | |||
Vitamin K and Osteoporosis | Nutrients | 2020 | 183 | 221 | |||
Fracture risk following intermission of osteoporosis therapy | Osteoporosis International | 2019 | 287 | 1 | |||
Further Nonvertebral Fracture Reduction Beyond 3 Years for Up to 10 Years of Denosumab Treatment | Journal of Clinical Endocrinology and Metabolism | 2019 | 320 | 1 | |||
RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass | Journal of Clinical Investigation | 2019 | 409 | 341 | |||
Associations between radius low-frequency axial ultrasound velocity and bone fragility in elderly men and women | Osteoporosis International | 2019 | 286 | 1 | |||
Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective study | The Lancet Diabetes & Endocrinology | 2019 | 342 | 0 | |||
Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis | Osteoporosis International | 2019 | 321 | 1 | |||
Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis | Advances in Therapy | 2019 | 266 | 135 | |||
Relationship Between Bone Mineral Density T‐Score and Nonvertebral Fracture Risk Over 10 Years of Denosumab Treatment | Journal of Bone and Mineral Research | 2019 | 340 | 183 | |||
Higher rates of osteoporosis treatment initiation and persistence in patients with newly diagnosed vertebral fracture when introduced in inpatients than later in outpatients | Osteoporosis International | 2019 | 300 | 1 | |||
Consensus Statement on the Use of Bone Turnover Markers for Short-Term Monitoring of Osteoporosis Treatment in the Asia-Pacific Region | Journal of Clinical Densitometry | 2019 | 261 | 163 | |||
Diabetes and fracture risk | Primer on the metabolic bone diseases and disorders of mineral metabolism | 2019 | 278 | 3 | |||
Hip muscle and hand-grip strength to differentiate between older fallers and non-fallers: a cross-sectional validity study | Clinical Interventions in Aging | 2018 | 540 | 218 | |||
Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension | Journal of Bone and Mineral Research | 2018 | 416 | 1 | |||
Romosozumab FRAME Study: A Post Hoc Analysis of the Role of Regional Background Fracture Risk on Nonvertebral Fracture Outcome | Journal of Bone and Mineral Research | 2018 | 403 | 0 | |||
Evaluation of Radius Microstructure and Areal Bone Mineral Density Improves Fracture Prediction in Postmenopausal Women | Journal of Bone and Mineral Research | 2018 | 591 | 0 | |||
Fermented dairy products consumption is associated with attenuated cortical bone loss independently of total calcium, protein, and energy intakes in healthy postmenopausal women | Osteoporosis International | 2018 | 435 | 6 | |||
β-Klotho deficiency shifts the gut-liver bile acid axis and induces hepatic alterations in mice | American Journal of Physiology. Endocrinology and Metabolism | 2018 | 380 | 4 | |||
Interaction between LRP5 and periostin gene polymorphisms on serum periostin levels and cortical bone microstructure | Osteoporosis International | 2018 | 570 | 1 | |||
FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to Denosumab | Journal of Bone and Mineral Research | 2018 | 395 | 0 | |||
Osteoporosis: Romosozumab to rebuild the foundations of bone strength | Nature Reviews Rheumatology | 2018 | 436 | 0 | |||
Ostéoporose | Revue médicale suisse | 2018 | 309 | 2 | |||
Phosphate wasting disorders in adults | Osteoporosis International | 2018 | 390 | 1 | |||
Recipient rs1045642 Polymorphism Is Associated With Office Blood Pressure at 1-Year Post Kidney Transplantation: A Single Center Pharmacogenetic Cohort Pilot Study | Frontiers in Pharmacology | 2018 | 507 | 208 | |||
Selective inhibition of Src family kinases by SU6656 increases bone mass by uncoupling bone formation from resorption in mice | Bone | 2018 | 399 | 2 | |||
Functional Performances on Admission Predict In-Hospital Falls, Injurious Falls, and Fractures in Older Patients: A Prospective Study | Journal of Bone and Mineral Research | 2018 | 498 | 3 | |||
Ostéoporose chez l'insuffisant rénal: quelle évaluation et quel traitement? Place de la biopsie osseuse | Revue médicale suisse | 2018 | 367 | 1 | |||
The C-Terminal Intact Forms of Periostin (iPTN) Are Surrogate Markers for Osteolytic Lesions in Experimental Breast Cancer Bone Metastasis | Calcified Tissue International | 2018 | 354 | 0 | |||
Prevention of fractures in patients with osteoporosis | The Lancet | 2018 | 444 | 1 | |||
Intra-rater reliability of hip abductor isometric strength testing in a standing position in older fallers and non-fallers | European Review of Aging and Physical Activity | 2018 | 439 | 190 | |||
Ostéoporose | Revue médicale suisse | 2018 | 405 | 109 | |||
Diagnosis and management of bone fragility in diabetes: an emerging challenge | Osteoporosis International | 2018 | 388 | 209 | |||
Les métamorphoses du traitement de l'ostéoporose | Revue médicale suisse | 2017 | 371 | 22 | |||
Evaluation of hip abductor and adductor strength in the elderly: a reliability study | European review on aging and physical activity | 2017 | 470 | 216 | |||
Serum Levels of a Cathepsin-K Generated Periostin Fragment Predict Incident Low-Trauma Fractures in Postmenopausal Women Independently of BMD and FRAX | Journal of Bone and Mineral Research | 2017 | 503 | 0 | |||
Development of a New Immunoassay for Human Cathepsin K-Generated Periostin Fragments as a Serum Biomarker for Cortical Bone | Calcified Tissue International | 2017 | 495 | 1 | |||
Cathepsin K Controls Cortical Bone Formation by Degrading Periostin | Journal of Bone and Mineral Research | 2017 | 439 | 1 | |||
IOF Compendium of Osteoporosis | 2017 | 1,153 | 407 | ||||
Peripheral skeleton bone strength is positively correlated with total and dairy protein intakes in healthy postmenopausal women | The American journal of clinical nutrition | 2017 | 628 | 3 | |||
Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study | BMC musculoskeletal disorders | 2017 | 462 | 199 | |||
Retrospective evaluation of serum CTX levels after denosumab discontinuation in patients with or without prior exposure to bisphosphonates | Osteoporosis International | 2017 | 489 | 2 | |||
Mechanisms of diabetes mellitus-induced bone fragility | Nature reviews. Endocrinology | 2017 | 511 | 0 | |||
Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO/ASCO | Swiss Medical Weekly | 2017 | 461 | 207 | |||
Prepubertal Impact of Protein Intake and Physical Activity on Weight-Bearing Peak Bone Mass and Strength in Males | The Journal of clinical endocrinology and metabolism | 2017 | 520 | 0 | |||
Structural Basis of Bone Fragility in Young Subjects with Inflammatory Bowel Disease: A High-resolution pQCT Study of the SWISS IBD Cohort (SIBDC) | Inflammatory Bowel Diseases | 2017 | 542 | 1 | |||
Traitement médicamenteux de l'ostéoporose: durée et procédure après la fin du traitement | Swiss Medical Forum | 2017 | 358 | 1 | |||
Diabetes and Bone | Calcified tissue international | 2017 | 432 | 1 | |||
Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting | Osteoporosis International | 2017 | 427 | 0 | |||
hypophosphatasie de l'adulte | Revue médicale suisse | 2017 | 484 | 6 | |||
Jusqu'où et jusqu'à quand traiter l'ostéoporose? | Revue médicale suisse | 2017 | 382 | 101 | |||
Fracture Prospectively Recorded From Prepuberty to Young Adulthood: Are They Markers of Peak Bone Mass and Strength in Males? | Journal of Bone and Mineral Research | 2017 | 482 | 0 | |||
Within and across-sex inheritance of bone microarchitecture | The Journal of clinical endocrinology and metabolism | 2017 | 1,492 | 10 | |||
Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis | Therapeutic advances in musculoskeletal disease | 2016 | 510 | 0 | |||
Le traitement séquentiel présente des avantages | Leading Opinions. Médecine Interne | 2016 | 378 | 1 | |||
Osteoporosis drug effects on cortical and trabecular bone microstructure: a review of HR-pQCT analyses | BoneKEy Reports | 2016 | 391 | 158 | |||
Traitement de l'ostéoporose : quel médicament et pour qui? | La gazette médicale - info@gériatrie | 2016 | 490 | 787 | |||
Influence of Fatigue Loading and Bone Turnover on Bone Strength and Pattern of Experimental Fractures of the Tibia in Mice | Calcified tissue international | 2016 | 552 | 3 | |||
Low Lean Mass Predicts Incident Fractures Independently From FRAX: a Prospective Cohort Study of Recent Retirees | Journal of bone and mineral research | 2016 | 572 | 7 | |||
The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club | Osteoporosis international | 2016 | 444 | 0 | |||
Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture | Archives of osteoporosis | 2016 | 484 | 209 | |||
Periostin action in bone | Molecular and cellular endocrinology | 2016 | 396 | 0 | |||
Mechanisms in Endrocrinology: Mechanisms and evaluation of bone fragility in type 1 diabetes mellitus | European journal of endocrinology | 2016 | 439 | 1 | |||
Occupation-dependent loading increases bone strength in men | Osteoporosis international | 2016 | 632 | 3 | |||
Romosozumab Treatment in Postmenopausal Women with Osteoporosis | The New England journal of medicine | 2016 | 871 | 1,341 | |||
Santé osseuse des retraités genevois | Revue médicale suisse | 2015 | 483 | 2 | |||
Gene–Diet Interactions on Bone | Nutrition and Bone Health | 2015 | 624 | 1 | |||
Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years | Osteoporosis international | 2015 | 494 | 0 | |||
Periostin expression contributes to cortical bone loss during unloading | Bone | 2015 | 531 | 1 | |||
Calcinose cutanée associée aux connectivites | Revue médicale suisse | 2015 | 1,049 | 3 | |||
Taxonomy of rare genetic metabolic bone disorders | Osteoporosis international | 2015 | 528 | 0 | |||
Additive Genetic Effects on Circulating Periostin Contribute to the Heritability of Bone Microstructure | The Journal of clinical endocrinology and metabolism | 2015 | 590 | 0 | |||
Sauvons l'ostéoporose | Revue médicale suisse | 2015 | 445 | 0 | |||
Prior ankle fractures in postmenopausal women are associated with low areal bone mineral density and bone microstructure alterations | Osteoporosis international | 2015 | 564 | 1 | |||
Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial | The Lancet. Diabetes & endocrinology | 2015 | 524 | 0 | |||
Osteocytic targets in the treatment of osteoporosis | Osteoporosis international | 2014 | 451 | 0 | |||
The role of teriparatide in sequential and combination therapy of osteoporosis | Schweizerische medizinische Wochenschrift | 2014 | 654 | 1 | |||
Association of LRP5 genotypes with osteoporosis in Tunisian post-menopausal women | BMC musculoskeletal disorders | 2014 | 704 | 150 | |||
Current challenges in the treatment of osteoporosis: an opportunity for bazedoxifene | Current medical research and opinion | 2014 | 494 | 0 | |||
Goal-directed treatment of osteoporosis in Europe | Osteoporosis international | 2014 | 505 | 1 | |||
Future directions for new medical entities in osteoporosis | Baillière's best practice & research. Clinical endocrinology & metabolism | 2014 | 460 | 0 | |||
Fractures ostéoporotiques: pas seulement chez les femmes | Revue médicale suisse | 2014 | 473 | 0 | |||
Novel Genetic Models of Osteoporosis by Overexpression of Human RANKL in Transgenic Mice | Journal of bone and mineral research | 2014 | 602 | 0 | |||
Tracking of Environmental Determinants of Bone Structure and Strength Development in Healthy Boys: An Eight-Year Follow Up Study on the Positive Interaction Between Physical Activity and Protein Intake From Prepuberty to Mid-Late Adolescence | Journal of bone and mineral research | 2014 | 619 | 1 | |||
Impaired Musculoskeletal Response to Age and Exercise in PPARβ −/− Diabetic Mice | Endocrinology | 2014 | 511 | 411 | |||
Fracture history of healthy premenopausal women is associated with a reduction of cortical microstructural components at the distal radius | Bone | 2013 | 531 | 0 | |||
Zoledronate Effects on Systemic and Jaw Osteopenias in Ovariectomized Periostin-Deficient Mice | PloS one | 2013 | 642 | 305 | |||
Effect of a multifactorial fall-and-fracture risk assessment and management program on gait and balance performances and disability in hospitalized older adults: a controlled study | Osteoporosis international | 2013 | 594 | 436 | |||
Effects of an Interleukin-15 Antagonist on Systemic and Skeletal Alterations in Mice with DSS-Induced Colitis | The American journal of pathology | 2013 | 523 | 0 | |||
Association of Circulating Sclerostin With Bone Mineral Mass, Microstructure, and Turnover Biochemical Markers in Healthy Elderly Men and Women | The Journal of clinical endocrinology and metabolism | 2013 | 629 | 0 | |||
Eliminating the need for fasting with oral administration of bisphosphonates | Therapeutics and clinical risk management | 2013 | 579 | 324 | |||
Diabète et ostéoporose | Revue médicale suisse | 2013 | 487 | 0 | |||
Periostin Deficiency Increases Bone Damage and Impairs Injury Response to Fatigue Loading in Adult Mice | PloS one | 2013 | 582 | 299 | |||
Peak bone mass and its regulation | Pediatric Bone, Second Edition | 2012 | 494 | 2 | |||
A botulinum toxin-derived targeted secretion inhibitor downregulates the GH/IGF1 axis | The Journal of clinical investigation | 2012 | 719 | 0 | |||
Postmenopausal osteoporosis treatment with antiresorptives: Effects of discontinuation or long-term continuation on bone turnover and fracture risk-a perspective | Journal of bone and mineral research | 2012 | 545 | 0 | |||
Osteoporosis in young adults: pathophysiology, diagnosis, and management | Osteoporosis international | 2012 | 651 | 998 | |||
Antidepressant medications and osteoporosis | Bone | 2012 | 567 | 0 | |||
Deletion of β-adrenergic receptor 1, 2, or both leads to different bone phenotypes and response to mechanical stimulation | Journal of bone and mineral research | 2012 | 527 | 0 | |||
Infections in postmenopausal women with osteoporosis treated with denosumab or placebo: coincidence or causal association? | Osteoporosis international | 2012 | 583 | 0 | |||
Physical activity increases bone mineral density in children with type 1 diabetes | Medicine and science in sports and exercise | 2012 | 631 | 1 | |||
Behandlung der Osteoporose mit Denosumab | Therapeutische Umschau | 2012 | 545 | 0 | |||
Fractures in Healthy Females Followed from Childhood to Early Adulthood Are Associated with Later Menarcheal Age and with Impaired Bone Microstructure at Peak Bone Mass | The Journal of clinical endocrinology and metabolism | 2012 | 606 | 0 | |||
Improvement of bone strength with teriparatide: hip as well as spine? | IBMS boneKEy | 2012 | 393 | 0 | |||
Regulation of beta catenin signaling and parathyroid hormone anabolic effects in bone by the matricellular protein periostin | Proceedings of the National Academy of Sciences of the United States of America | 2012 | 604 | 0 | |||
Deficiency in the NADPH oxidase 4 predisposes towards diet-induced obesity | International journal of obesity | 2012 | 696 | 5 | |||
Effect of music-based multitask training on gait, balance, and fall risk in elderly people: a randomized controlled trial | Archives of internal medicine | 2011 | 656 | 2 | |||
Do RANKL inhibitors (denosumab) affect inflammation and immunity? | Osteoporosis international | 2011 | 590 | 713 | |||
Fractures during childhood and adolescence in healthy boys: relation with bone mass, microstructure, and strength | The Journal of clinical endocrinology and metabolism | 2011 | 614 | 366 | |||
Prévention des chutes par une méthode d'exercice en musique (rythmique Jaques-Dalcroze) | Revue médicale suisse | 2011 | 660 | 2 | |||
Longitudinal change in hip fracture incidence after starting risedronate or raloxifene: an observational study | Journal of bone and mineral metabolism | 2011 | 524 | 227 | |||
Early post-transplantation hypophosphatemia is associated with elevated FGF-23 levels | European journal of endocrinology | 2011 | 565 | 392 | |||
Bisphosphonates in periodontitis: Friend or foe? | IBMS boneKEy | 2011 | 702 | 0 | |||
Denosumab and bisphosphonates: Different mechanisms of action and effects | Bone | 2011 | 642 | 0 | |||
Protéines et croissance osseuse | Archives de pédiatrie | 2011 | 536 | 1 | |||
Pubertal timing and body mass index gain from birth to maturity in relation with femoral neck BMD and distal tibia microstructure in healthy female subjects | Osteoporosis international | 2011 | 611 | 279 | |||
Effects of long-term supplementation with omega-3 fatty acids on longitudinal changes in bone mass and microstructure in mice | The Journal of nutritional biochemistry | 2011 | 543 | 1 | |||
Traitement de l'ostéoporose par les agents biologiques | Je veux en savoir plus | 2011 | 451 | 0 | |||
Mechanisms inducing low bone density in duchenne muscular dystrophy in mice and humans | Journal of bone and mineral research | 2011 | 542 | 0 | |||
Decreased bone turnover in children and adolescents with well controlled type 1 diabetes | Journal of pediatric endocrinology & metabolism | 2010 | 581 | 2 | |||
Comparing and contrasting the effects of strontium ranelate and other osteoporosis drugs on microarchitecture | Osteoporosis international | 2010 | 560 | 310 | |||
Ostéoporose: du diagnostic ostéodensitométrique à l'évaluation du risque absolu de fracture | Journal für Mineralstoffwechsel | 2010 | 571 | 3 | |||
Pathophysiology of postmenopausal osteoporosis | Atlas of Postmenopausal Osteoporosis. Third Edition | 2010 | 502 | 0 | |||
Exercise and the skeleton: How it works and what it really does | IBMS boneKEy | 2010 | 899 | 1,378 | |||
Are osteoclasts needed for the bone anabolic response to parathyroid hormone? A study of intermittent parathyroid hormone with denosumab or alendronate in knock-in mice expressing humanized RANKL | The Journal of biological chemistry | 2010 | 747 | 0 | |||
Development of a new ELISA for serum periostin: evaluation of growth-related changes and bisphosphonate treatment in mice | Calcified tissue international | 2010 | 606 | 0 | |||
Age de la ménarche et risque d'ostéoporose au cours de la vie adulte | Mises au point cliniques d'endocrinologie, nutrition et métabolisme | 2010 | 486 | 2 | |||
An integration of genome-wide association study and gene expression profiling to prioritize the discovery of novel susceptibility Loci for osteoporosis-related traits | PLOS genetics | 2010 | 1,037 | 327 | |||
Inhibition of T cell-dependent and RANKL-dependent osteoclastogenic processes associated with high levels of bone mass in interleukin-15 receptor-deficient mice | Arthritis and rheumatism | 2010 | 507 | 0 | |||
β-Arrestin-biased parathyroid hormone ligands: A new approach to the development of agents that stimulate bone formation | Science translational medicine | 2009 | 527 | 0 | |||
The matricellular protein periostin is required for sost inhibition and the anabolic response to mechanical loading and physical activity | The Journal of biological chemistry | 2009 | 594 | 1 | |||
Neuropeptide Y knockout mice reveal a central role of NPY in the coordination of bone mass to body weight | PloS one | 2009 | 645 | 452 | |||
Beta-arrestin2 regulates parathyroid hormone effects on a p38 MAPK and NFkappaB gene expression network in osteoblasts | Bone | 2009 | 585 | 669 | |||
Osteoporosis management: a perspective based on bisphosphonate data from randomised clinical trials and observational databases | International journal of clinical practice | 2009 | 543 | 0 | |||
Mice lacking beta-adrenergic receptors have increased bone mass but are not protected from deleterious skeletal effects of ovariectomy | Endocrinology | 2009 | 580 | 0 | |||
The influence of pubertal timing on bone mass acquisition: a predetermined trajectory detectable five years before menarche | The Journal of clinical endocrinology and metabolism | 2009 | 563 | 1 | |||
Deleterious effect of late menarche on distal tibia microstructure in healthy 20-year-old and premenopausal middle-aged women | Journal of bone and mineral research | 2009 | 580 | 0 | |||
Continuous broad protection against osteoporotic fractures with strontium ranelate | Rheumatology | 2009 | 576 | 1 | |||
Beta-Arrestin2 regulates RANKL and ephrins gene expression in response to bone remodeling in mice | Journal of bone and mineral research | 2009 | 539 | 0 | |||
Differentiation of osteoporotic and neoplastic vertebral fractures by chemical shift {in-phase and out-of phase} MR imaging | European journal of radiology | 2009 | 575 | 0 | |||
Adrenergic control of bone remodeling and its implications for the treatment of osteoporosis | Journal of Musculoskeletal and Neuronal Interactions | 2008 | 528 | 0 | |||
PPARG by dietary fat interaction influences bone mass in mice and humans | Journal of bone and mineral research | 2008 | 556 | 0 | |||
High-protein intake enhances the positive impact of physical activity on BMC in prepubertal boys | Journal of bone and mineral research | 2008 | 550 | 0 | |||
Secondary prevention of osteoporotic fractures: why not apply the evidence? | Schweizerische medizinische Wochenschrift | 2008 | 510 | 0 | |||
Influence of age at menarche on forearm bone microstructure in healthy young women | The Journal of clinical endocrinology and metabolism | 2008 | 660 | 0 | |||
Caloric restriction decreases cortical bone mass but spares trabecular bone in the mouse skeleton: implications for the regulation of bone mass by body weight | Journal of bone and mineral research | 2008 | 560 | 0 | |||
Genomewide Association Studies in Osteoporosis: Have We Reached the Bottom of the Ocean or the Tip of the Iceberg? | IBMS boneKEy | 2008 | 526 | 0 | |||
Leptin and the sympathetic connection of fat to bone | Osteoporosis international | 2008 | 547 | 0 | |||
Contribution of gender-specific genetic factors to osteoporosis risk | Annals of human genetics | 2008 | 489 | 0 | |||
Site specificity of fracture prediction in children | Journal of bone and mineral research | 2008 | 464 | 0 | |||
Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis | JAMA | 2008 | 567 | 0 | |||
Human genetics of osteoporosis | Baillière's best practice & research. Clinical endocrinology & metabolism | 2008 | 592 | 2 | |||
Pathogenic mutations and polymorphisms in the lipoprotein receptor-related protein 5 reveal a new biological pathway for the control of bone mass | Current opinion in lipidology | 2005 | 527 | 0 | |||
LRP5 gene polymorphisms and idiopathic osteoporosis in men | Bone | 2005 | 525 | 0 | |||
beta-Arrestin2, interacting with phosphodiesterase 4, regulates synaptic release probability and presynaptic inhibition by opioids | Proceedings of the National Academy of Sciences of the United States of America | 2005 | 529 | 0 | |||
Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites | American journal of human genetics | 2004 | 536 | 0 | |||
Parathyroid hormone-related protein increases cAMP production in mammary epithelial cells | The American journal of physiology | 1993 | 531 | 0 |